- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05073276
Non- Vs Partial Controlled Weightbearing After Multiple Knee Ligament Reconstruction
Non-Weight Bearing Versus Partial Controlled Weightbearing During the First Six Weeks of Rehabilitation After Multiple Knee Ligament Reconstruction: a Randomized Controlled Trial
Study Overview
Detailed Description
Patients will be randomly assigned to one of two rehabilitation protocols for the first six weeks post-surgery:
- non-weightbearing
- partial weightbearing
An immobilizer brace in extension will be used from post-operative day 0 through 4 and a dynamic stabilizing posterior knee brace (Ossur) will be used from 5 days through 6 months post-surgery to protect against increased posterior translation forces due to gravity and while weightbearing for patients with PCL reconstructions.
Specific Aims
- Primary Aim: To determine if there is clinical equivalence in millimeters of posterior tibial translation on posterior stress radiographs at six months post-surgery between patients who are non-weightbearing versus partial controlled weightbearing during the first six weeks of post-surgical rehabilitation.
- Primary Aim: To determine if there is clinical equivalence in millimeters of valgus and/or varus compartment gapping on stress radiographs at six months post-surgery between patients who are non-weightbearing versus partial controlled weightbearing during the first six weeks of post-surgical rehabilitation.
- Secondary Aim: To determine if there is a difference in pain, edema, range of motion, gait, and quadriceps strength between groups.
The current standard of care for posterior cruciate ligament reconstruction and multiligament reconstruction is non-weightbearing for the first six weeks after surgery.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Kayla Seiffert
- Phone Number: 952-456-7085
- Email: research@tcomn.com
Study Contact Backup
- Name: Becky McGaver
- Phone Number: 952-456-7136
- Email: research@tcomn.com
Study Locations
-
-
Minnesota
-
Edina, Minnesota, United States, 55435
- Recruiting
- Twin Cities Orthopedics
-
Contact:
- Becky Stone
- Phone Number: 952-456-7136
- Email: research@tcomn.com
-
Contact:
- Robert F LaPrade, MD, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- ≥ 14 years old, <60
- Reconstruction of PCL alone
- Reconstruction of MCL alone
- Reconstruction of combined multiligament injuries (PCL+ (FCL, PLC, ACL, MCL))
- Reconstruction of multiligament injuries (ACL+MCL)
- Males or females
- Is willing and able to comply with the clinical trial plan and able to understand and sign the Patient Informed Consent Form.
Exclusion Criteria:
- < 14 years old
- >60 years old
- Pregnant
- Revision PCL reconstructions
- Previous or concurrent vascular injury (vascular bypass procedure)
- Associated fractures requiring concurrent surgery
- Concurrent meniscal root or radial repair surgery
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Non-weightbearing for the first six weeks after surgery
Not weightbearing after surgery
|
Patient is randomized to the weightbearing group the day after surgery.
|
|
Experimental: Partial weight -bearing for the first six weeks after surgery
Partial weightbearing will be defined as 40% of the patient's body weight.
|
Patient is randomized to the weightbearing group the day after surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gapping (mm) measured on Standard of Care Varus stress radiographs
Time Frame: Pre-operative
|
stress radiographs
|
Pre-operative
|
|
Gapping (mm) measured on Standard of Care Varus stress radiographs
Time Frame: 6 months post-surgery
|
stress radiographs
|
6 months post-surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Numeric Pain Scale (NPS) (0-10 rating)
Time Frame: Baseline and 6 months
|
Pain scale 0-100
|
Baseline and 6 months
|
|
Measurements by physical therapists (Edema, thigh circumference)
Time Frame: 4,7, and 10 months after surgery
|
Measurements with tape
|
4,7, and 10 months after surgery
|
|
Measurements by physical therapists (Quadriceps strength, gait analysis)
Time Frame: 4,7, and 10 months after surgery
|
Measurements by biomechanics lab
|
4,7, and 10 months after surgery
|
|
Patient reported outcome scores
Time Frame: Baseline, 3 months, 6 months, 1 year
|
Surveys: International Knee Documentation Committee (IKDC), Cincinnati Knee Rating System (Cincinnati), Knee injury and Osteoarthritis Outcome Score (KOOS), Tegner, Lysholm Knee Scoring Scale (Lysholm), and Veterans Rand 12 (VR-12) or Short Form-12 (SF-12) General Health Survey, lower extremity functional scale, Sports Medicine Questionnaire and survey/patient satisfaction
|
Baseline, 3 months, 6 months, 1 year
|
|
Measurements by physical therapists (range of motion)
Time Frame: 4,7, and 10 months after surgery
|
Measurements with goniometer
|
4,7, and 10 months after surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Robert F LaPrade, MD, PhD, Twin Cities Orthopedics
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RFL_NWB vs PWB-Multi-Knee Lig
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.